AlphaGenix代理

详细介绍

产品咨询

世界*实验材料供应商AlphaGenix上海金畔生物为其中国代理，AlphaGenix 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， AlphaGenix 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

AlphaGenix 中国代理，AlphaGenix 上海代理，AlphaGenix北京代理， AlphaGenix 广东代理，AlphaGenix 江苏代理 AlphaGenix 湖北代理, AlphaGenix 天津, AlphaGenix 黑龙江代理, AlphaGenix内蒙古代理, AlphaGenix 吉林代理, AlphaGenix 福建代理, AlphaGenix 江苏代理, AlphaGenix 浙江代理, AlphaGenix 四川代理,

公司：www.alphagenix.com

美国一家大的抗体生产厂家,并在干细胞领域有其*的产品,包括,细胞,培养基等

AlphaGenix is a life science company that develops novel products and technologies for basic and clinical research with a particular emphasis on stem cell biology, biomaterials and regenerative medicine.  In addition, the company conducts regenerative medicine research that involves basic science and translational preclinical research using stem cell regulatory network discoveries and novel preclinical studies utilizing animal models.

The company is engineering human extracellular matrix （ECM） proteins for clinical applications. These natural biomaterials play a role in treating a wide array of diseases including, but not limited to, neurological disorders and hereditary muscle diseases.  Currently these products are in preclinical development with the intent of entering clinical trials within the next 24 months.

AlphaGenix's human ECM, AlphaMax, is being used as a scaffold for tissue engineering, reconstruction and repair.  In addition, it has shown efficacy in a xenograft tumor model in reducing tumor formation in conjunction with stem cells. It was determined that AlphaMax was able to cause a significant reduction in tumor size due to its ability to augment delivery of the stem cells to the tumor site and facilitated tumor killing by the therapeutic stem cells.

The company is also investigating the use of cell therapy for the treatment of traumatic brain injury （TBI）.  In a rat model of TBI, stem cell therapy after moderate TBI improves motor and cognitive function.  The placement and method of delivery are important factors in cell survival and may improve cell survival and cognitive recovery.

AlphaGenix has its laboratories and corporate offices at the Purdue Research Park in West Lafayette, IN and has research collaborations with Purdue University.  The laboratories include a state-of-the-art molecular and cell biology facility and advanced scientific imaging equipment.

alphagenix目录：

Fluorescent Calcium Indicators and Related Products (钙离子测定试剂及其衍生产品)

Fluorescent Cl, pH and Zinc Indicators (其他荧光离子探针(pH, Cl))

Fluorescent Membrane and Membrane Potential Dyes (生物膜及生物膜电位差荧光染料)

Natural Products and Their Fluorescent Conjugates (生物毒素及它们的荧光偶合物)

Biochemical Reagents for Nitric Oxide (NO) Studies (用于NO研究的生化试剂)

Enzyme Substrates (生物酶底物)

Reactive Dyes and Related Reagents (具有Thiol 反应活性的荧光染料)

Biotin Derivatives

Nucleic Acid Stains and Products for Genomics Studies (核酸染色剂及基因研究试剂)

Cytosolic Tracers and Related Products

Protein Conjugates

Proteomics products (蛋白质研究试剂)

上海金畔生物科技有限公司

AlphaGenix公司介绍

详细介绍

产品咨询

公司：www.alphagenix.com

美国一家大的抗体生产厂家,并在干细胞领域有其*的产品,包括,细胞,培养基等

AlphaGenix is a life science company that develops novel products and technologies for basic and clinical research with a particular emphasis on stem cell biology, biomaterials and regenerative medicine.  In addition, the company conducts regenerative medicine research that involves basic science and translational preclinical research using stem cell regulatory network discoveries and novel preclinical studies utilizing animal models.

The company is engineering human extracellular matrix （ECM） proteins for clinical applications. These natural biomaterials play a role in treating a wide array of diseases including, but not limited to, neurological disorders and hereditary muscle diseases.  Currently these products are in preclinical development with the intent of entering clinical trials within the next 24 months.

AlphaGenix’s human ECM, AlphaMax, is being used as a scaffold for tissue engineering, reconstruction and repair.  In addition, it has shown efficacy in a xenograft tumor model in reducing tumor formation in conjunction with stem cells. It was determined that AlphaMax was able to cause a significant reduction in tumor size due to its ability to augment delivery of the stem cells to the tumor site and facilitated tumor killing by the therapeutic stem cells.

The company is also investigating the use of cell therapy for the treatment of traumatic brain injury （TBI）.  In a rat model of TBI, stem cell therapy after moderate TBI improves motor and cognitive function.  The placement and method of delivery are important factors in cell survival and may improve cell survival and cognitive recovery.

AlphaGenix has its laboratories and corporate offices at the Purdue Research Park in West Lafayette, IN and has research collaborations with Purdue University.  The laboratories include a state-of-the-art molecular and cell biology facility and advanced scientific imaging equipment.